Characteristics | All patients (N = 73,071), n (%) | Patients without AMI (N = 72,469), n (%) | Patients with AMI (N = 602), n (%) |
---|---|---|---|
Age, median (IQR) | 45 (38–52) | 45 (38–52) | 53 (48–59) |
Male gender | 59,514 (81.4) | 58,981 (81.4) | 533 (88.5) |
Region | |||
 East | 17,523 (24.0) | 17,354 (24.0) | 169 (28.1) |
 Mid-West | 13,532 (18.5) | 13,411 (18.5) | 121 (20.1) |
 South | 33,271 (45.5) | 33,014 (45.6) | 257 (42.7) |
 West | 8745 (12.0) | 8690 (12.0) | 55 (9.1) |
Year of ART initiation | |||
 2009 | 24,435 (33.4) | 24,127 (33.3) | 308 (51.2) |
 2010 | 9729 (13.3) | 9636 (13.3) | 93 (15.5) |
 2011 | 10,274 (14.1) | 10,190 (14.1) | 84 (14.0) |
 2012 | 8605 (11.8) | 8559 (11.8) | 46 (7.6) |
 2013 | 7830 (10.7) | 7794 (10.8) | 36 (6.0) |
 2014 | 12,198 (16.7) | 12,163 (16.8) | 35 (5.8) |
Ever substance abuse | 13,395 (18.3) | 13,152 (18.2) | 243 (40.4) |
Ever alcohol abuse | 3093 (4.2) | 3039 (4.2) | 54 (9.0) |
Ever tobacco use | 11,849 (16.2) | 11,587 (16.0) | 262 (43.5) |
Body mass index > 24.9 | 1511 (2.07) | 1503 (2.07) | 8 (1.33) |
Essential hypertension | 7450 (10.2) | 7336 (10.1) | 114 (19.0) |
Diabetes mellitus or receipt of anti-hyperglycemic agentsa | 4128 (5.7) | 4052 (5.6) | 76 (12.6) |
Chronic Kidney Disease | 729 (1.0) | 701 (1.0) | 28 (4.7) |
Dyslipidemia | 8616 (11.8) | 8496 (11.7) | 120 (19.9) |
Lipodystrophy | 224 (0.3) | 220 (0.3) | 4 (0.7) |
Pre-existing heart diseaseb | 1754 (2.4) | 1688 (2.3) | 66 (11.0) |
Receipt of medications for heart diseasec | 14,336 (19.6) | 14,074 (19.4) | 262 (43.5) |
History of stroke | 211 (0.3) | 204 (0.3) | 7 (1.2) |
Hepatitis B | 959 (1.3) | 953 (1.3) | 6 (1.0) |
Hepatitis C | 1520 (2.1) | 1500 (2.1) | 20 (3.3) |
History of cancer | 5499 (7.5) | 5442 (7.5) | 57 (9.5) |